Login / Signup

Has the risk of liver re-transplantation improved over the two decades?

Miho AkabaneYuki BekkiYuki ImaokaYosuke InabaCarlos O EsquivelAllison KwongMarc L MelcherKazunari Sasaki
Published in: Clinical transplantation (2023)
While short-term re-LT outcomes improved, challenges persist compared to DCD. Further enhancements are required, with ongoing research focusing on optimizing risk stratification models and allocation systems for better LT outcomes.
Keyphrases
  • type diabetes
  • metabolic syndrome
  • bone marrow
  • mesenchymal stem cells
  • glycemic control
  • insulin resistance
  • weight loss